PeptiDream, PDRadiopharma and Curium Group Enroll First Patient to Registrational Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan

Upcoming Conference Presentation at EANM’25（PeptiDream Inc）

Launch of “onti dandori” – A Scheduling Module for the “onti” System for Nuclear Medicine Exposure Dose Management

Bridgea DISPENSER Now Equipped with Liquid Collection Function — Enhancing Operational Efficiency and Safety in Radiopharmaceutical Preparation

PDRadiopharma Receives Approval for Expanded Indication of Raiatt MIBG-I131 for Neuroblastoma